Skip to main content

Ambry Genetics Buys an Illumina Genome Analzyer

NEW YORK (GenomeWeb News) – Ambry Genetics said Friday that it has purchased a Genome Analyzer from Illumina that it plans to use in conducting pharmacogenomics services for customers.
 
The Aliso Viejo, Calif.-based genetic testing firm said that it has already begun running research samples on the GA with its probe capture technology.
 
“To date we’ve run assays with hundreds of genes on the probe capture technology; with new bioinformatics software, SNP annotation and exon identification, we’ve been able to find many novel mutations,” Ambry CEO Charles Dunlop said in a statement.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.